Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Telogen is an active phase with important biological processes, not a resting phase.

New drugs are improving treatment for hormone-related diseases in small pets.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.

Treating both the mind and skin together, especially by managing stress, can greatly improve outcomes for skin disorders linked to psychological issues.

Childhood obesity is rising globally due to various factors, and early prevention and healthy lifestyle changes are crucial.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

HFMs can help study hair growth and test potential hair growth drugs.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Hair color is determined by different melanins and changes with age.

The symposium concluded that understanding how different species repair tissue and how this changes with age can help advance regenerative medicine.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Zinc helps reduce the severity of depression.

Surface-modified nanostructured lipid carriers can improve hair growth treatments.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Mothers have more hair proteins than their children, with age-related differences in protein patterns, and some proteins in hair could indicate early childhood development.

The document is a detailed medical reference on skin and genetic disorders.

PCOS may have evolved as an advantage in past environments with food scarcity.

The document concludes that treatment for excessive hair growth depends on the cause, with options including hair removal methods and medications like anti-androgens or insulin-sensitizing drugs.